Chronic kidney disease (CKD) is a global health burden with a high economic cost to health
systems and represents an independent risk factor for cardiovascular disease. Myocardial …

The prevalence of coronary artery disease (CAD) in patients with chronic kidney disease
(CKD) is a major cause of morbidity and mortality. Myocardial revascularization in patients …

Contrast nephropathy (CN) is a common cause of iatrogenic acute renal failure. Its incidence
rises with the growing use of intra-arterial contrast in older patients for diagnostic and …

Over past years, there has been a progressive increase in percutaneous endovascular
procedures in patients with chronic renal disease, owing to the high incidence of vascular …

Key Points Pre‐procedural “at risk” assessment for Contrast Induced Acute Kidney Injury (CI‐
AKI). Peri‐procedural volume expansion is essential. Contrast Minimus: Practice “As Low as …

The administration of iodinated contrast media (CM) is integral to many cardiovascular
procedures. While it is clear that CM provide significant diagnostic benefit, there is some risk …

Contrast-induced nephropathy can be defined as the development of transient or permanent
renal dysfunction due to use of nephrotoxic contrast agents like in coronary angiography …

Dr Pershad underlines the fact that prevention of contrast-induced nephropathy (CIN)
requires multiple measures including the limitation of contrast volume, careful hydration with …

Over the last few years there has been a progressive increase in percutaneous
endovascular procedures in patients with chronic renal disease, due to the high incidence of …

Patients with chronic kidney disease (CKD) have an increased risk of obstructive coronary
artery disease (CAD), whereas patients with end stage renal disease who are receiving …